Pulmonx Corp — Director's Dealing 2025

Mar 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2025-03-03

Reporting Person: Williamson Steven S. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-03	Common Stock	S	27689	$7.14	Disposed	194342	Direct
2025-03-03	Common Stock	A	181696	—	Acquired	376038	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-03	Employee Stock Option (right to buy)	$8.29	A	128395	Acquired	2035-03-02	Common Stock (128395)	Direct

Footnotes

F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 15, 2024.

F2: Includes 2,500 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2025.

F3: Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025.

F4: The shares subject to the option vest in 48 equal monthly installments from the grant date on March 3, 2025.